Rausing laboratory of Lund - Tumor section
41 – 50 of 83
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Anti-C1-inactivator treatment of glioblastoma
(
- Contribution to journal › Article
-
Mark
Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma
(
- Contribution to journal › Article
-
Mark
Alzheimer´s and other neurodegenerative cognitive disorders. : A strategy to find cause and cure
(
- Contribution to journal › Article
-
Mark
Tumor Regression and Cure Depends on Sustained Th1 Responses
(
- Contribution to journal › Article
-
Mark
The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams
(
- Contribution to journal › Article
-
Mark
Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1
(
- Contribution to journal › Article
-
Mark
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
(
- Contribution to journal › Article
-
Mark
Electro Enhanced Gene Tumour Therapy with IL-18 and IFNgamma transfected tumour cell vaccine : In memory of Bengt Widegren d. 2014
(
- Contribution to journal › Article
- 2017
-
Mark
T Cell Activation Pathways : B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles
(
- Contribution to journal › Article
-
Mark
A clinical distance measure for evaluating treatment plan quality difference with Pareto fronts in radiotherapy
(
- Contribution to journal › Article